Human Control of Robot Weaponry Urged by Arms Control Groups

A new generation of weapons that are increasingly capable of targeting and attacking without the involvement of people require the maintaining human control over them, says two international arms control groups in a report. An emerging United States military strategy that will count on technology advantages and increasingly depend on weapons systems that blend humans…

Sale of Standard Products Business being considered by NXP: Bloomberg

Citing sources familiar with the matter Bloomberg reported that NXP Semiconductors NV is considering a sale of its standard products business and has received interest from Chinese buyers. NXP makes semiconductor parts such as diodes, transistors and other standard chip products used in consumer electronics such as phones, television sets and cars. Sources that were…

Senior Staff Suspended Amid SFO Probe as Tata Steel UK Crisis Deepens

A criminal investigations has been by the British Serious Fraud Office has been prompted by the suspension of two senior Tata Steel executives along with 10 other people suspended over forgery allegations. Mark Broxholme, the managing director of the company’s specialty steels and bar business was suspended last November, reported The Guardian. Another senior executive…

China being overtaken by India’s Thirst for Oil

India is becoming the new China in the energy world. As India’s economy expands by luring the type of manufacturing that China is trying to shun, the world’s second-most populous nation is increasingly becoming the center for oil demand growth. India is trying to hedge its future energy needs by investing in new production at…

Europe Approves Bristol-Myers Squibb Opdivo for Advanced RCC

The European Commission has approved Opdivo (nivolumab) monotherapy for an additional indication in advanced renal cell carcinoma (RCC) after prior therapy in adults, announced Bristol-Myers Squibb Company. To demonstrate an overall survival (OS) benefit versus a standard of care in this patient population, Opdivo is the first and only PD-1 immune checkpoint inhibitor approved in Europe. The approval…